Learn more about the life and work of SpotitEarly’s canine partners
At SpotitEarly, our dogs are not just part of our groundbreaking screening process — they are valued partners…
The transformative role of AI in SpotitEarly’s cancer screening process
AI is reshaping industries worldwide and its scope to impact the healthcare sector is already evident. In a…
The future of cancer screening? A deep dive into SpotitEarly’s LUCID bio-hybrid platform
SpotitEarly is changing the landscape of cancer screening with LUCID, its groundbreaking bio-hybrid platform. Combining the natural sensitivity…
The Rainbow Study – SpotitEarly’s breakthrough in detecting multiple cancers
Early detection is widely recognized as one of the most powerful tools in the fight against cancer. SpotitEarly…
The science behind dogs’ exceptional cancer detection capabilities
Dogs have long been celebrated for their extraordinary sense of smell. Whether it’s used to track missing persons…
Why is breath analysis a game changer for early cancer detection?
Given the multiple challenges associated with traditional screening approaches, the prospect that a simple breath test could transform…
Discover SpotitEarly’s groundbreaking approach to early cancer detection.
Cancer remains one of the leading causes of death worldwide. According to the US National Cancer Institute at…
Transforming cancer screening: Dr. Len Lichtenfeld’s new role at SpotitEarly
SpotitEarly was thrilled to welcome Dr. J. Leonard “Len” Lichtenfeld as its first chief medical officer in November…
The journey of a breath sample: From ordering to results
At SpotitEarly, we’re transforming the way cancer screening works, making it more accessible, accurate and user-friendly. Our innovative…
How does SpotitEarly collaborate with researchers and hospital systems?
At SpotitEarly, collaboration is at the heart of innovation. We’re working hand-in-hand with leading researchers, healthcare organisations and…